CBRS Stock Drops Post-Earnings, But UBS Calls Sell-Off A ‘Compelling Buying Opportunity’ Amid Wall Street Split
Mizuho and UBS both see the post-earnings sell-off in Cerebras as a buying opportunity, despite taking different approaches to their price targets. Mizuho lowered its price target to $300 from $310 but maintained an ‘Outperform’ rating and said it was a “buyer of the stock” following the decline. UBS raised its Cerebras price target to … Read more